GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 86 filers reported holding GENERATION BIO CO in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,962 | -38.6% | 19,779 | -10.9% | 0.01% | -47.1% |
| Q2 2023 | $122,029 | -7.5% | 22,187 | -27.7% | 0.02% | -5.6% |
| Q1 2023 | $131,881 | +130.5% | 30,670 | +110.6% | 0.02% | +100.0% |
| Q4 2022 | $57,221 | -73.5% | 14,560 | -64.1% | 0.01% | -72.7% |
| Q3 2022 | $216,000 | -43.5% | 40,607 | -30.2% | 0.03% | -2.9% |
| Q2 2022 | $382,000 | -45.6% | 58,164 | -39.2% | 0.03% | -43.3% |
| Q1 2022 | $702,000 | +169.0% | 95,615 | +159.5% | 0.06% | +200.0% |
| Q4 2021 | $261,000 | -23.2% | 36,843 | +191.4% | 0.02% | -9.1% |
| Q2 2021 | $340,000 | – | 12,644 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |